| Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681) |
|---|
| 05/02/2002 | EP0946579B1 Novel erythromycin derivatives, method for preparing them and their use as medicine |
| 04/30/2002 | US6380395 Anticancer agents |
| 04/30/2002 | US6380172 Monomeric lipophilic oligosaccharide antibiotic compositions |
| 04/30/2002 | US6380168 Administering 3-o-.beta.-glucopyranosyl(1-6)-.beta.-d-glucopyranosyl indole, 2-s-.beta.-d-glucopyranosyl-3-o-.beta.-d-glucopyranosyl-2-merc aptoindole for increasing blood flow to skin |
| 04/30/2002 | US6380166 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols |
| 04/30/2002 | CA2062496C Avermectin compounds with a 6,5-spiroketal ring system |
| 04/25/2002 | WO2002032919A2 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance |
| 04/25/2002 | WO2002032918A2 Ketolide antibacterials |
| 04/25/2002 | WO2002032917A1 Macrolides |
| 04/25/2002 | WO2002032916A2 Sixteen-membered macrolide compounds |
| 04/25/2002 | WO2002032233A2 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin |
| 04/25/2002 | US20020049168 Derivative of apoptolidin |
| 04/25/2002 | CA2426593A1 Ketolide antibacterials |
| 04/25/2002 | CA2420012A1 6-o-substituted erythromycin derivatives having improved gastrointestinal tolerance |
| 04/24/2002 | EP1035858B1 Use of ginkgo biloba extracts for preparing a medicine |
| 04/24/2002 | CN1346362A Avermectin derivatives |
| 04/24/2002 | CN1083250C Foodstuff containing sesamol-3-glucoside from sesame seed |
| 04/23/2002 | CA2229504C Flavanone-containing composition |
| 04/18/2002 | WO2002030943A1 Erythromycin derivative having novel crystal structures and processes for their production |
| 04/18/2002 | US20020044965 Side effect profile reduction |
| 04/17/2002 | EP0749305B1 Process for making avermectin/zein compositions |
| 04/17/2002 | CN1345327A 阿维菌素衍生物 Avermectin derivatives |
| 04/16/2002 | US6372895 Fluorogenic compounds |
| 04/11/2002 | US20020042380 Topical application of ascorbic acid compounds for augmenting the synthesis of epidermal ceramides |
| 04/09/2002 | US6369036 Enhanced activity of natamycins in the form of a solution or solvate crystal form; prevents spoilage by mold in foods |
| 04/09/2002 | US6369035 3,6-hemiketals from the class of 9A-azalides |
| 04/04/2002 | WO2002026753A1 Erythromycin derivatives and medicines containing the same |
| 04/04/2002 | WO2002026220A2 Taxoid conjugates as antimitotic and antitumor agents |
| 04/04/2002 | WO2001047507A3 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 04/04/2002 | US20020040050 Immunosuppressive agents |
| 04/04/2002 | US20020040007 Novel macrolide antibiotics |
| 04/04/2002 | CA2423483A1 Taxoid conjugates as antimitotic and antitumor agents |
| 04/04/2002 | CA2418260A1 Erythromycin derivative and medicament comprising the same |
| 04/03/2002 | EP1192139A1 Preparation of quinoline-substituted carbonate and carbamate derivatives |
| 04/03/2002 | EP1192129A2 Pharmaceutical compounds |
| 04/03/2002 | EP1172109A9 Compositions for preventing and treating type i allergy |
| 04/03/2002 | EP0946580B1 Novel erythromycin derivatives, method of preparation and application as medicines |
| 04/03/2002 | EP0937094B1 Method for the production of ivermectin |
| 04/03/2002 | CN1343216A Erythromycin derivatives |
| 04/03/2002 | CN1343215A 6-O-substituted macrolides having antibacterial activity |
| 04/03/2002 | CN1082055C Process for extracting spiramycin from fermented filter liquor |
| 04/02/2002 | US6365574 Gradual crystallization of azithromycin from ethanol by the addition of a minimal amount of water; hydrophobic |
| 04/02/2002 | US6365179 Conjugate having a cleavable linkage for use in a liposome |
| 03/28/2002 | WO2002024146A2 Methods of decreasing or preventing pain using spicamycin derivatives |
| 03/28/2002 | US20020038017 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 03/28/2002 | US20020037864 2'-Propionate clarithromycin dodecyl sulfate and its preparation and pharmaceutical composition containing the same |
| 03/27/2002 | EP1191031A1 3-modified leucomycin derivatives |
| 03/27/2002 | EP1189915A1 Process for the production of azithromycin |
| 03/27/2002 | EP1189914A1 DERIVATIVES OF 4'-DEMYCAROSYL-8a-AZA-8a-HOMOTYLOSIN |
| 03/27/2002 | EP1189913A1 Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
| 03/27/2002 | EP1189912A1 Novel crystalline forms of a macrolide antibiotic |
| 03/27/2002 | CN1342163A Ketolide antibiotics |
| 03/26/2002 | US6362168 Antiparasitic agents |
| 03/21/2002 | WO2000078772A3 Antibiotic agents |
| 03/21/2002 | US20020035072 Method for enhancing mutant enzyme activities in lysosomal storage disorders |
| 03/21/2002 | US20020034797 Modified modular pks with retained scaffold |
| 03/20/2002 | CN1341117A 5-glycosyloxy-6-hydroxynaphtho [2,3-f] quinoline-7,12 dione having anticancer activities |
| 03/19/2002 | CA2055912C Novel erythromycin derivatives, their preparation process, the new intermediated obtained and their application as drugs |
| 03/14/2002 | WO2001059126A3 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 03/13/2002 | EP1185629A1 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds |
| 03/12/2002 | US6355620 C-2 modified erythromycin derivatives |
| 03/07/2002 | WO2002017909A1 A therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028921 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 03/07/2002 | US20020028920 Processes for preparing clarithromycin polymorphs |
| 03/07/2002 | US20020028781 Antibiotics |
| 03/07/2002 | US20020028473 Components of dense microspheres derived from mammalian brain tissue detectable in cerebrospinal fluid |
| 03/07/2002 | CA2382687A1 A therapeutic agent of osteoporosis comprising an active ingredient of quercetin derivatives |
| 03/06/2002 | EP1183369A1 Polyketides and their synthesis |
| 03/05/2002 | US6353096 Process of use in converting the 4″(S)-OH functional group of the cladinose unit of an azamacrolide to 4″(R)-NH2 |
| 03/05/2002 | US6352983 Antibiotics and bactericides |
| 02/28/2002 | WO2002016380A1 New macrolides with antibacterial activity |
| 02/28/2002 | WO2002015842A2 Process for preparation of anhydrous azithromycin |
| 02/28/2002 | US20020026038 Slurrying a solid comprising clarithromycin Form 0 in water; macrolide antibiotic related to erythromycin A |
| 02/28/2002 | US20020025938 Bactericides |
| 02/28/2002 | US20020025937 9-oxime erythromycin derivatives |
| 02/28/2002 | US20020025936 Motilide compounds |
| 02/28/2002 | CA2419873A1 Process for preparation of anhydrous azithromycin |
| 02/27/2002 | EP1181300A1 6-o-carbamate ketolide derivatives |
| 02/27/2002 | EP1181299A1 C-2 modified erythromycin derivatives |
| 02/27/2002 | EP1181298A1 Novel 8a- and 9a-15-membered lactams |
| 02/27/2002 | EP1150990A4 Erythromycin a compounds and process for preparing the same |
| 02/27/2002 | CN1337402A Synthesis process of antineoplastic drug etoposide |
| 02/26/2002 | US6350733 Aromatic derivatives substituted by a ribose, their method of preparation and application as medicine |
| 02/21/2002 | WO2002014338A1 Novel pseudoerythromycin derivatives |
| 02/21/2002 | WO2002014251A1 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof |
| 02/21/2002 | WO2002013834A1 Nocathiacin antibiotics prepared by biotransformation or chemical methods |
| 02/21/2002 | WO2000069875A9 C-2 modified erythromycin derivatives |
| 02/21/2002 | US20020022598 Agent for inducing apoptosis |
| 02/20/2002 | EP1180110A1 13-methyl-erythromycin derivatives |
| 02/20/2002 | CN1336932A Macrolides with anti-inflammatory activity |
| 02/14/2002 | WO2002012261A1 Avermectin derivatives |
| 02/14/2002 | WO2002012260A1 Macrolide antibiotics |
| 02/14/2002 | WO2002012259A1 Erythromycin 2'-proprionate dedecyl sulfanate (salt), process for its preparation and pharmaceutical composition |
| 02/14/2002 | WO2002012256A1 Method for purification of acarbose |
| 02/14/2002 | WO2002012248A1 Avermectin derivatives |
| 02/14/2002 | US20020019355 Oxacyclotetradecane derivatives against methicillin resistant strains of staphylococcus |
| 02/14/2002 | US20020019353 Single-dose administration |
| 02/14/2002 | US20020018821 Process for the purification of a red fruit extract containing anthocyanosides, extract obtained from the process and use of said extract |
| 02/14/2002 | CA2419044A1 Macrolide antibiotics |